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ABSTRACT
DNA methylation-dependent restriction enzymes
have many applications in genetic engineering and
in the analysis of the epigenetic state of eukaryotic
genomes. Nevertheless, high-resolution structures
have not yet been reported, and therefore mechan-
isms of DNA methylation-dependent cleavage are
not understood. Here, we present a biochemical
analysis and high-resolution DNA co-crystal struc-
ture of the N6-methyladenine (m6A)-dependent re-
striction enzyme R.DpnI. Our data show that
R.DpnI consists of an N-terminal catalytic PD-(D/
E)XK domain and a C-terminal winged helix (wH)
domain. Surprisingly, both domains bind DNA in a
sequence- and methylation-sensitive manner. The
crystal contains R.DpnI with fully methylated target
DNA bound to the wH domain, but distant from the
catalytic domain. Independent readout of DNA
sequence and methylation by the two domains
might contribute to R.DpnI specificity or could help
the monomeric enzyme to cut the second strand
after introducing a nick.
INTRODUCTION
Restriction modification (RM) systems are composed of a
restriction endonuclease and a DNA methyltransferase,
and provide bacteria with protection against non-self
DNA (1). In most cases, the self DNA is marked by
methylation, introduced in a sequence-specific manner
by the methyltransferase. Non-self DNA, which lacks
the methylation mark, is cleaved by the endonuclease.
However, the rule that self, but not non-self DNA is
modified, is not universal. Presumably, under the
pressure from RM systems, some phages have evolved
to incorporate a wide variety of modified DNA bases
into their genomes. In a further escalation of the ‘arms
race’ between bacteria and their pathogens, this has then
led to the evolution of modification-dependent restriction
enzymes, which treat unmodified DNA as ‘self’ and
modified DNA as ‘non-self’.
Modification-dependent restriction enzymes are a very
diverse group, and in the current classification of nucleases
fall either into the type IIM (where ‘M’ stands for
modification-dependent) or type IV class, depending on
subunit composition, biochemical properties and specifi-
city of cleavage (2). Type IV McrA belongs to the bba-Me
(or HNH) superfamily of nucleases, and is, at least in vivo,
specific for the Ym5CGR target sequence (where Y is C or
T and R is G or A) (3). Type IV McrBC is an oligomeric
protein complex, which recognizes pairs of Rm5C sites
separated by 40–2000 bp of non-specific DNA. The
enzyme consists of the GTPase McrB, which is also
required for the recognition of methylation, and the
McrC subunit that harbors a PD-(D/E)XK motif and
catalyzes DNA cleavage (4,5). Type IV Mrr is a cryptic
endonuclease thought to act on modified adenines, whose
activity appears to be triggered by some forms of stress
(6). The enzyme causes genotoxicity when expressed in
bacteria containing certain type III DNA m6A
methyltransferases. A strong anti-correlation between
close homologues of Mrr and these methyltransferases
has been observed in proteobacterial genomes (7). Some
enzymes related to Mrr, including the recently
characterized R.MspJI, have been shown to cleave DNA
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that is methylated on cytosines (8). There are also many
other methylation-specific activities (e.g. R.AoxI, R.BisI,
R.BlsI, R.GlaI, R.GluI, R.KroI and R.PscI), which have
not yet been ascribed to molecularly defined complexes
and their domain composition and mechanism of
cleavage remains unknown.
R.DpnI is the best known modification-dependent
restriction endonuclease that recognizes methylated
adenines rather than cytosines. The enzyme was origin-
ally isolated from Streptococcus (formerly Diplococcus)
pneumoniae (9). In vivo, it protects bacteria against
phages that have been propagated on Dam+ hosts.
This is possible thanks to its specificity for Gm6ATC,
the product of Dam methylation. In vitro, R.DpnI
cleaves GATC sites efficiently when these are fully
methylated (i.e. in both strands) and also
hemi-methylated, when the enzyme is used in high con-
centration. It is a blunt end cutter that cleaves DNA in
the middle of the recognition sequence (10–12), rather
than distantly from it like many other modification-
dependent restriction endonucleases. Due to this methy-
lation dependence, R.DpnI has been classified as a type
IIM enzyme. Unlike most other type II restriction endo-
nucleases, it is a monomer in solution (10). Due to its
unusual properties, it is widely used in biotechnological
applications. A standard site-directed mutagenesis
strategy (Stratagene) exploits the enzyme to remove a
non-mutated template that has been propagated in a
Dam+ host, but not a PCR product carrying the
mutation. The preference of R.DpnI for fully methylated
over hemi-methylated sites has been used to create
‘ultra-rare’ cutting enzymes by combining it with
suitably chosen m6A methyltransferases (13–15).
R.DpnI is also useful for studies of bacterial DNA rep-
lication, because digestion with low amounts of the
enzyme cleaves all but freshly replicated DNA (12).
Despite the widespread use of R.DpnI in biotechnology
and the interest in other modification-dependent enzymes,
which could be applied to studies of epigenetic modi-
fications of eukaryotic DNA, the present understanding
of this group of enzymes is very limited. In particular,
crystal or NMR structures have not been reported,
and the mechanisms of modification-dependent cleavage
remain mysterious. In a first step towards a better
understanding of methylation dependent cleavage, we
present a detailed biochemical characterization of




The dpnI gene as well as separate domain genes were
cloned by standard techniques into the pET28 vector
with a PreScission cleavable N-terminal His-tag (16).
The QuickChange method (Stratagene) was used to intro-
duce key residue substitutions into the R.DpnI coding
sequence in the expression construct.
Protein preparation
ER2925 Escherichia coli strain (New England Biolabs)
lysogenized with DE3 element using DE3 Lysogenization
Kit (Novagene) was used as an expression host. The ex-
pression was induced with 0.2mM IPTG and carried out
overnight at 25C. After centrifugation, cell pellets were
resuspended in buffer A: 15% (v/v) glycerol, 50mM
PIPES (pH 7), 300mM NaCl, 2.5mM imidazole, 10mM
b-mercaptoethanol. Cells were disrupted in French press
at 20 000 psi and the lysate was cleared by 30min centri-
fugation at 15000g. The supernatant was applied on a
His-Select Nickel Affinity Gel (Sigma) equilibrated with
buffer A. The resin was washed with buffer B: 15 % (v/v)
glycerol, 50mM PIPES (pH 7), 2M NaCl, 2.5mM imid-
azole, 1% igepal, 10mM b-mercaptoethanol and next with
buffer C: 15% (v/v) glycerol, 50mM PIPES (pH 7),
300mM NaCl, 5mM imidazole, 10mM b-merca-
ptoethanol. R.DpnI was eluted with buffer D: 15 % (v/
v) glycerol, 50mM PIPES (pH 7), 300mM NaCl, 250mM
imidazole, 10mM b-mercaptoethanol. For His-tag
cleavage, the protein was 5-fold diluted with buffer E:
15% (v/v) glycerol, 50mM PIPES (pH 7), 50mM NaCl,
10mM b-mercaptoethanol. The PreScission protease
cleavage was done overnight at 4C. The protease was
removed on a MonoS column (GE Healthcare)
equilibrated with buffer E. R.DpnI was eluted with
50–1000mM gradient of NaCl in buffer E. Enzyme con-
taining fractions were pooled together and the buffer was
exchanged on a PD-10 column (GE Healthcare) to buffer
F: 15% (v/v) glycerol, 50mM PIPES (pH 7), 150mM
NaCl, 10mM b-mercaptoethanol, 50mM arginine and
50mM glutamic acid. For crystallization trials, buffer F
was supplemented with 5mM CaCl2 (buffer G).
Cleavage assays
The cleavage assays were performed for 2 h at 37C in
20 ml reaction volume with the standard Tango buffer
(Fermentas). The concentration of R.DpnI was 37.5 nM.
Due to the low yield of the PD-(D/E)XK domain expres-
sion, its concentration could not be determined. Dam
methylated pBR322 plasmid DNA in the final concentra-
tion of 5.6 nM (GATC sites concentration: 123.2 nM) was
used as a substrate unless stated otherwise. The non-
methylated plasmids were isolated from a Dam host.
The Hia5-methylated pBR322 plasmid was isolated from
a Dam+host and additionally in vitro methylated by Hia5
methyltransferase (a kind gift of M. Radlinska).
Cleavage of substrates with one and two GATC sites
The assay was performed with dsDNA with either two
GATC sites (distance between sites 141 bp, flanking
sequences 460 and 272 bp) or with either of the sites sep-
arately mutated to a GGCC sequence. The substrates were
prepared from the pUC18 plasmid methylated in vivo in
Dam+E. coli cells. The dsDNA fragments were cut out of
the plasmid and its derivatives with R.SapI and R.SspI
restriction endonucleases prior to cleavage with R.DpnI.
The reaction products were resolved by agarose gel elec-
trophoresis. The appropriate fragments were cut out of
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the gel and purified by Gel Out kit (A&A Biotechnology).
The reaction progress was measured by monitoring the
decrease of the substrate at indicated time points for 2 h
(Supplementary Figure S1). R.DpnI and dsDNA were
used in the concentrations of 37.5 pM and 9.25 nM,
respectively.
Nitrocellulose filter binding assays
The relative binding affinities were determined in a filter
binding assay (17). Substrate oligonucleotides, including
the methylated ones (Metabion) were radiolabeled with
[g-33P]ATP (Hartmann Analytic) and T4 polynucleotide
kinase (Fermentas). Mixtures (200ml total volume in
buffer F containing double-stranded oligonucleotide
(15 nM) and R.DpnI (500 nM) were incubated for 30min
at 25C. Reaction mixtures were filtered through a
0.22 -mm nitrocellulose filter (Whatman) in a Dot-Blot ap-
paratus (Bio-Rad). Each well was washed three times with
200 ml of binding buffer. Dried filters were exposed to a
phosphoimager screen overnight. Images were scanned on
a Storm Phosphoimager (GE Healthcare) and retained
radioactivity was quantified using ImageQuant software
(GE Healthcare).
Crystallization
The DNA duplex for the crystallization experiments was
obtained by annealing 50-CTGGm6ATCCAG-30 oligo-
nucleotide with itself by slow cool-down from 95C to
4C during 30min. The R.DpnI mediated cleavage of
the short oligonucleotide was confirmed electrophoretic-
ally (Supplementary Figure S2). The protein in 10mg/ml
concentration was provided in buffer G and mixed in 1:1
molar ratio with target DNA duplex also in buffer G to
form a tight complex. Crystal growth was initiated by
mixing the protein-DNA solution in 3:1 ratio with crys-
tallization buffer B (200mM potassium sulfate, 100mM
betaine, 20% w/v PEG 3350, pH 6.8). Crystal growth
occurred at 20C over a period of 30 days. Prior to
data collection, crystals were transferred to a 3:1 mix of
crystallization buffer B and 100% glycerol and
flash-cryocooled to 100K.
Structure determination and refinement
High resolution (2.05 A˚) and multiple anomalous diffrac-
tion data (to about 2.9 A˚ resolution, collected at 1.2833
and 1.2835 A˚ wavelengths) were collected at the Diamond
Light Source synchrotron. The SHELXC program (18)
confirmed the presence of anomalous signal. SHELXD
(19) was used to interpret the anomalous signal in terms
of a heavy atom structure with three anomalous scatterers
that were later confirmed to coincide with two Zn2+
binding sites and one additional site on the symmetry
axis. The original MAD density was subjected to cyclic
2-fold averaging and solvent flattening, taking care to
avoid excessive modification of the phases, particularly
for the high-resolution reflections. The resulting density
was then of sufficient quality for the ARP/wARP
program to deliver a 75% complete model of the protein
and some DNA fragments (20). The model was improved
by mapping the best fragments of both protein monomers
onto the local symmetry mates. DNA was mostly built
manually using the COOT program (21). Refinement
was carried out with the REFMAC (22) and CNS (23)
programs. The resulting quality indicators are
summarized in Supplementary Table S1 and appear satis-
factory for a structure of about 2 A˚ resolution. Atomic
coordinates of the refined model and corresponding struc-
ture factors have been deposited to Protein Data Bank
with the accession code 4ESJ.
RESULTS
Expression of a stable and active variant of R.DpnI
R.DpnI is DNA methylation-dependent, and thus its
expression should not, in general, be toxic in the E. coli
Dam strain ER2925. A lysogenized version of the strain
that expresses T7 polymerase was used to overproduce
the enzyme under the control of the T7 promoter.
As the R.DpnI amino acid sequence contained predicted
thrombin and TEV cleavage sites, we expressed a variant
with PreScission cleavable N-terminal histidine tag,
which was soluble, but prone to degradation. Mass spec-
trometry was used to detect the cleavage site between
R134 and R135. This suggested that R.DpnI was
hydrolyzed by the E. coli OmpT protease. In order to
suppress the cleavage, we replaced the less conserved
R134 with alanine and asparagine (the latter occurs nat-
urally in R.DpnI homologues). The asparagine, but not
the alanine mutation was well tolerated. Therefore, all
further experiments were carried out with this variant of
the protein.
Domain organization and classification
R.DpnI had been grouped with restriction endonucleases
that are difficult to classify into the major phylogenetic
classes (24). However, a closer inspection indicated that
the enzyme is a two-domain protein with a predicted
N-terminal PD-(D/E)XK domain and C-terminal HTH
domain. PD-(D/E)XK enzymes tend to be very selective
about metal co-factors and typically accept only either
Mg2+ or Mn2+. In contrast, both bba-Me (HNH) and
GIY-YIG endonucleases are more promiscuous in their
requirement for divalent metal ions (25,26) and phospholi-
pase-like enzymes (such as R.BfiI) do not require a metal
ion co-factor altogether (27). We therefore tested the
activity of R.DpnI in the presence of either Mg2+, Ca2+
or Mn2+. Like other PD-(D/E)XK superfamily enzymes
(28), R.DpnI was active in the presence of Mg2+or Mn2+,
but not Ca2+ ions (Figure 1A).
Biochemical validation of the active site prediction
Bioinformatic analysis suggested that D53, E64 and K66
were part of the R.DpnI PD-(D/E)XK motif. Despite the
name, the proline is frequently not conserved in the PD-
(D/E)XK family (24). Its role in R.DpnI could either be
played by the A52 just upstream of D53, or by a nearby
proline (P50). In order to verify the assignment of candi-
date ‘signature’ residues, P50, D53, E64, L65 and K66
were all individually substituted with alanines. P50
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turned out to be unimportant for the catalytic activity.
The L65A variant nicked DNA at the tested concentration
and probably also cleaved the plasmid at a very slow rate.
All other changes essentially abolished activity of R.DpnI
as expected (Figure 1B).
Determination of sequence specificity
R.DpnI is known to cleave Gm6ATC, but not
non-methylated target sites. We noticed that ‘star’ activity
of R.DpnI against other adenine-methylated sequences
would not compromise a Dam host (without other
adenine methyltransferases) and would therefore not be
selected against. In order to test for such activity, we took
advantage of the recent discovery of the fairly unspecific
adenine methyltransferase Hia5, which methylates the
majority of adenine residues in a DNA template (29). We
digested either Dam or Dam andHia5-methylated pBR322
plasmid with R.DpnI. At high concentration of the endo-
nuclease, theHia5-methylated DNAwas cleaved at a larger
number of sites than the Dam-methylated DNA. This indi-
cates that R.DpnI can cleave DNA with methylated
adenine in contexts other than Gm6ATC (Figure 2A).
The activity was specific for R.DpnI and not due to a
contaminating m6A-dependent nuclease from the E. coli
lysate, because it was abolished by amino acid replacements
in the R.DpnI active site (Supplementary Figure S3). In
order to characterize the star activity more closely, we
used R.DpnI to digest pBR322 plasmid DNA that was
methylated by either Dam alone or Dam and Hia5. The
digestion fragments were ligated into a blunt end recipient
vector (pUC18). Sequencing of 61 independent clones con-
firmed that R.DpnI cleaved Dam-modified DNA only at
(methylated) GATC sites. In Dam and Hia5-modified
DNA, (methylated) GATC was the most frequently
cleaved site, but many other sites, primarily those with
only one non-cognate base, were also found (Figure 2B
and Supplementary Table S2). We note that m6A methyla-
tion was not explicitly tested in this assay (any cleavage at
non-modified sites does contribute to the outcome of this
experiment) and that star activity leading to sticky end
products would not be detected.
Determination of binding affinity
It is known that R.DpnI cleaves fully methylated DNA
much more efficiently than hemi-methylated DNA (12),
but it is not clear whether this effect is purely dependent
on catalytic rates, or whether binding effects also play a
role. We therefore assayed R.DpnI in a filter-binding
assay against fully methylated (mDNA), hemi-methylated
(hmDNA) or non-methylated oligo DNA (nmDNA), as
well as an additional set of oligos with scrambled se-
quences (smDNA, ssmDNA and snmDNA) in the
presence of Ca2+ ions (Figure 3 and Supplementary
Table S3A). We conclude from the results of these
experiments that both methyl groups and the correct
sequence context are important for tight DNA binding
by the enzyme.
Crystallization and structure determination
In order to understand the structural basis of the R.DpnI
properties, the protein was crystallized in complex with a
stoichiometric amount of fully methylated substrate
DNA. The latter was obtained by self-annealing of the
palindromic 50-CTGGm6ATCCAG-30 oligonucleotide. In
order to prevent cleavage of the substrate DNA, crystal-
lization drops contained Ca2+ instead of Mg2+ ions.
Crystals grew in space group C2 and diffracted to 2.05 A˚
resolution at the Diamond Light Source. Due to the
presence of two CXXC motifs in the R.DpnI sequence,
it was anticipated that the enzyme should bind a zinc ion.
Figure 1. Biochemical validation of R.DpnI active site prediction. (A) Divalent metal ion dependence of the plasmid DNA cleavage by R.DpnI. The
reaction buffer contained: no divalent metal ions, 10mM MgCl2, 10mM CaCl2 or 10mM MnCl2. (B) Cleavage activity of R.DpnI variants with
single amino acid substitutions within the active site. M: molecular mass marker, control: non-cleaved substrate.
7566 Nucleic Acids Research, 2012, Vol. 40, No. 15
Although Zn2+ ions were not added to any of the buffers
during protein purification and crystallization, the metal
remained bound to R.DpnI according to the X-ray
fluorescence signal and could be exploited to phase the
diffraction data.
Gross structure of the R.DpnI–DNA complex
Crystals contain two copies of monomeric R.DpnI in
complex with target DNA in the asymmetric unit.
The two monomers are not related by a 2-fold axis with
each other or with symmetry mates, therefore it can be
rigorously excluded that a physiologically relevant dimer
is formed in the crystals. R.DpnI activity as a monomer is
also supported by the observation that in digests with this
enzyme, nicks accumulate before double-strand breaks are
formed (Supplementary Figure S4). The two molecules of
R.DpnI with their bound DNA duplexes are nearly super-
imposable. Therefore, it suffices to discuss one monomer
only. As predicted by the bioinformatic analysis, each
R.DpnI chain consists of an N-terminal catalytic PD-
(D/E)XK domain (residues 1–182) and a C-terminal
domain (residues 183–254). Each DNA duplex is bound
closely to a single C-terminal domain, but is distant to the
PD-(D/E)XK domain of the same protein molecule.
Therefore, the DNA complex corresponds to the DNA
bound state of the C-terminal part of the enzyme but
does not capture catalytically productive complex of its
N-terminal part (Figure 4A).
Structure of the N-terminal PD-(D/E)XK domain
The R.DpnI N-terminal catalytic domain has the typical
PD-(D/E)XK-fold. DALI structure comparisons with
other structures in the Protein Data Bank identified
R.PvuII (30) and R.ThaI (31) as most similar PD-(D/
E)XK endonucleases. The superpositions identify residue
E25 of R.DpnI as the conserved active site glutamate in the
helix upstream of the PD-(D/E)XK b-sheet (Supple-
mentary Figure S5). Structure based assignment of the
other catalytic residues is consistent with the bioinformatic
analysis and with the results of the site-directed mutagen-
esis experiments (Figure 1B). R.DpnI catalytic domain
possesses an unusual feature, a Zn2+ ion, which is
liganded by four cysteine residues. Two of them are
located between the catalytic glutamate (E25) and the
‘PD’ aspartate (D53), the other two are in a hairpin
between the ‘D’ (D53) and the ‘EXK’ (E64 to K66).
Figure 2. Determination of R.DpnI sequence selectivity. (A) R.DpnI mediated cleavage of Dam and Hia5-methylated plasmid DNA in comparison
to Dam-methylated and non-methylated DNA. R.DpnI concentration: 37.5 nM, pBR322 plasmid concentration: 5.6 nM, GATC sites concentration:
123.2 nM and SATS sites concentration: 537.6 nM. The wedge indicates decreasing concentration of R.DpnI (37.5 nM, 3.75 nM, 375 pM and 37.5
pM). M: molecular mass marker, c: non-cleaved DNA, Dam mDNA: Dam-methylated plasmid, nmDNA: non-methylated plasmid (isolated from a
Dam E. coli strain), Hia5 mDNA: Hia5-methylated plasmid isolated from a Dam+ E. coli strain. (B) Sequence logo of R.DpnI selectivity on Dam
(upper logo) and Dam and Hia5-methylated DNA (lower logo). pBR322 Dam or Dam+Hia5-methylated plasmid was cleaved with R.DpnI and the
resulting fragments were cloned to pUC18. A total of 61 independent clones were sequenced. Logos were generated by the WebLogo program (48).
Figure 3. Binding of R.DpnI to different 21-mer oligo DNAs.
Abbreviations for oligonucleotide duplexes: mDNA: fully methylated
Gm6ATC, hmDNA:hemi-methylatedGm6ATC,nmDNA:non-methylated
GATC, smDNA: methylated scrambled sequence (CTm6AG), ssmDNA:
methylated sequence with scrambled positions 1 and 4 and unchanged
m6A position (Cm6ATG). snmDNA: non-methylated scrambled sequence
(CTAG). For full oligo sequences see Supplementary Table S4.
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Structure of the C-terminal domain in complex
with target DNA
The C-terminal domain contains the predicted HTH motif
and is best described as a winged helix (wH). It consists of
3 a-helices and a 3-stranded b-sheet. The most C-terminal
helix (‘recognition helix’) inserts directly into the major
groove of the target DNA, where the two m6A methyl
groups are located in close proximity to each other.
Both of them are buried in the pockets of the wH
domain. The walls of the pockets are built from the
main chain of the recognition helix and the hydrophobic
parts of its polar side chains (E228, R231 and Q232 for
one and E228, K229 and Q232 for the other methyl group;
Figure 4B). Hydrogen bonding interactions between
the wH domain and the target sequence are focused on
the purine bases and except for a single one donated by the
side chain of Q232 do not involve any of the pyrimidines
(Figure 4C). The biological relevance of the crystallo-
graphically observed binding mode is supported by the
structure comparisons. Many winged helix domains,
including some with remarkably high similarity to the
one of R.DpnI, bind to the major groove of the DNA,
although the precise orientation of the oligoduplex might
vary. The superposition of protein and DNA is
particularly striking, e.g. for the comparison of R.DpnI
and human Foxo3A DNA-binding domain (PDB code
2UZK, DOI:10.2210/pdb2uzk/pdb; Supplementary
Figure S6).
Relevance of the wH binding mode to DNA
In order to further verify the relevance of the crystallo-
graphically observed DNA binding mode in solution, the
R.DpnI wH domain (residues 181-254) was expressed in
isolation in E. coli. The domain bound to oligo DNA
containing fully methylated Gm6ATC sequence, although
not as tightly as the entire enzyme. The binding was specific,
because it was reduced by the replacement of a key residue
in the wH domain (R231) with alanine, both in the context
of the full-length enzyme and of the wH domain alone
(Figure 5 and Supplementary Table S3). Moreover, it was
sensitive to the DNA sequence and methylation state. The
wH domain bound fully methylated DNA much more
effectively than hemi-methylated or non-methylated
DNA. A scrambled sequence was bound with considerable
affinity only if the m6As were staggered in the correct
way, despite overall weaker binding. The specificity of the
Figure 4. Crystal structure of the R.DpnI-DNA complex. (A) Overview of the R.DpnI structure. The active site residues of the catalytic domain
(blue) are indicated in magenta and the residues responsible for sequence recognition by the wH domain (green) are in yellow. Two loops that could
not be reliably traced in the electron density (residues 46–49 and 131–136) were marked by the dotted lines. (B) Detail of the binding of the central
m6A-T pairs to the winged helix domain. (C) Sequence recognition by the winged helix domain. The composite omit map was contoured at 1 s.
Figure 5. Binding assay of R.DpnI and its variants to different oligo DNAs. (A) Relative binding of different R.DpnI variants to methylated oligo
DNA (mDNA). (B) Relative binding of the R.DpnI wH domain to different oligo DNAs. (C) Relative binding of the R.DpnI R231A variant to
different oligo DNAs. The oligo coding is analogous as in Figure 3 (for data quantification see Supplementary Table S3, for sequences see
Supplementary Table S4).
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wH domain for the Gm6ATC target sequence was further
confirmed by a competition experiment. When used in
excess, it protected DNA against digestion with R.DpnI,
but notR.AluI, which recognizes a scrambled version of the
sequence with non-methylated adenine (AGCT), also cuts
with blunt ends (Supplementary Figure S7). We concluded
from these data that the binding mode of the wH domain to
DNA observed in the crystal was biologically relevant and
that the wH domain probes both DNA methylation state
and its sequence.
Effects of changes in the wH domain on the activity of
full length R.DpnI
In order to confirm the role of thewHdomain in the context
of full length R.DpnI, we selected residues within 5 A˚
spheres around the two m6A methyl groups (E228, K229,
R231, Q232 and Q235) and substituted them one by one to
alanines. Although the crystal structure indicates that the
five residues are involved in the formation of the
hydrophobic pockets as well as in direct hydrogen bonds
with the bases, we did not see strong effects on the activity
of R.DpnI against a plasmid containing fully methylated
Gm6ATC sites (Supplementary Figure S8). However, in
contrast to the wild-type enzyme, some of the variants did
not cleave hemi-methylated DNA under our assay condi-
tion (Figure 6). The effects of alterations to the wH domain
in the context of the full-length enzyme were confirmed in a
filter binding assay. The full-length enzyme with alanine
instead of R231 still bound well to methylated DNA, but
not to hemi-methylated or non-methylated DNA or to
other control substrates (Figure 5C). Together, the effects
of substitutions in the wH domain suggested that the cata-
lytic domainmay have sequence andmethylation specificity
of its own.
Expression and properties of the catalytic domain
The PD-(D/E)XK domain of R.DpnI could be produced
in isolation (using the same expression system as for the
full length protein), but the yield was very low. Therefore,
the experiments with this domain were carried out in
crude cell extracts. The catalytic domain in isolation
cleaved Dam-methylated, but not non-methylated DNA
(Figure 7A). Hypermethylation of Dam-methylated DNA
with Hia5 did not change the pattern of digestion
fragments that were obtained after incubation with the
catalytic domain (Figure 7B). Star activity was not
observed, but this might have been due to the limited
amounts of PD-(D/E)XK domain that we could express.
We conclude from these experiments that the R.DpnI
catalytic domain on its own cleaves DNA in a methyla-
tion- and sequence-specific manner.
A model for the interaction of the catalytic
domain with DNA
As we could not produce enough of the catalytic domain
to attempt co-crystallization with target DNA, we had to
resort to molecular modeling to investigate the cleavage
complex. Automatic structure comparisons with models in
the Protein Data Bank indicated that the catalytic domain
of R.DpnI was most similar to the R.PvuII monomer
(PDB accession code 1F0O) (30). Therefore, we con-
sidered R.PvuII for our modeling, but confirmed that
this particular choice did not influence our conclusions
Figure 6. Hemi-methylated DNA (cuthmDNA) cleavage by R.DpnI
variants with alanine substitutions in the wH domain. Control:
non-cleaved substrate. The sequence of the used oligo DNA is available
in Supplementary Table S4. R.DpnI concentration: 37.5 nM. dsDNA
concentration: 1 mM.
Figure 7. Properties of the PD-(D/E)XK domain. (A) Cleavage of Dam-methylated and non-methylated pUC18 DNA by R.DpnI and its catalytic
domain. (B) Cleavage of Dam and Dam and Hia5-methylated pBR322 DNA by R.DpnI and its catalytic domain. M: molecular mass marker,
control: non-cleaved substrate, ‘+’: Dam-methylated DNA, ‘’: non-methylated DNA, Dam: Dam-methylated plasmid, Hia5: Hia5-methylated
plasmid isolated from a Dam+ E. coli strain. R.DpnI concentration: 37.5 nM, pUC18 plasmid concentration: 9.0 nM, pUC18 GATC sites concen-
tration: 135 nM, pBR322 plasmid concentration: 5.6 nM, pBR322 GATC sites concentration: 123.2 nM and pBR322 SATS sites concentration:
537.6 nM.
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in a major way. In a first step, we mapped the monomeric
R.DpnI onto the two subunits of the R.PvuII dimer. In
the second step, we then overlaid this complex onto a
DNA duplex in the crystal, choosing the register so that
the cleavage sites were superimposed. Two possible
binding modes result, which reflect the need for two
docking events to make a double strand cut with a
single active site only (Supplementary Figure S9). The
modeling predicts that the catalytic domain of R.DpnI
approaches the DNA from the minor groove side, but
almost wraps around it to make some contacts from
the major groove side as well, particularly at the ends
and flanks of the recognition sequence. The described
modeling is too inaccurate to pinpoint sequence- or modi-
fication-specific contacts of the R.DpnI catalytic domain
with DNA. However, the model does identify candidate
residues that are located at the interface (Q18, R21, R126
and W138) or might take part in interactions if the
129–137 loop reorders in a productive complex (R135).
We have substituted all these residues separately to
alanines, and characterized the catalytic efficacy of the
resulting R.DpnI variants (Supplementary Figure S10).
All amino acid exchanges reduced the activity of the
enzyme. However, further cleavage experiments with an
excess of the mutant proteins also indicated that none of
the exchanges abolished activity completely. The Q18A
and R135A substitutions were tolerated best, suggesting
that these residues play a lesser role in DNA binding.
Together, the results of the mutagenesis experiments are
consistent at least qualitatively with the model for the
complex of the catalytic domain of R.DpnI with DNA.
Dependence of cleavage efficiency on
the number of GATC sites
The presence of two binding sites for the same target
sequence in a restriction endonuclease usually indicates
that the enzyme behaves as a type IIE enzyme, i.e. that
binding of the enzyme to an effector site is required to
license cleavage of the substrate site (32). In order to
probe the dependency of R.DpnI catalytic efficiency on
the presence of effector sites, we compared DNA cleavage
rates for substrates with either one or two target sequences
combined in the same DNA. For an enzyme that is not
influenced by remote sites, one would expect that the rate
of first cleavage in the substrate should not be higher than
the sum of rates for the substrates with only one site. This is
not observed and instead, the data indicate that the
presence of a second site within one DNA fragment influ-
ences R.DpnI cleavage efficiency. Residual cleavage of
substrates with only one site could either indicate activation
by another substrate in trans or a deviation from the ideal
type IIE behavior (Supplementary Figure S1).
Catalytic and wH domains in trans
For type IIE enzymes, the catalytic and effector domains
cooperate for DNA cleavage. The kinetic data suggest that
R.DpnI behaves in some ways like a type IIE enzyme and
that therefore the wH and catalytic domains of this enzyme
should also act synergistically. Does this still workwhen the
two domains are provided separately? In order to test this,
we pre-incubated substrate DNAwith an excess of R.DpnI
wH domain and then attempted to cleave this DNA with
either full-length enzyme or its catalytic domain, or a
control restriction endonuclease recognizing a different
site of the same size. Our data indicate that the wH
domain in isolation prevents cleavage by R.DpnI or its
catalytic domain, but lowers cleavage by the control endo-
nuclease only slightly. This effect is most likely due to the
competition of the winged helix domain with R.DpnI or its
catalytic domain for target sites on the DNA (Figure 8 and
Supplementary Figure S7).
DISCUSSION
Our analysis revealed that R.DpnI is a monomeric
restriction endonuclease with an N-terminal catalytic
PD-(D/E)XK domain and a C-terminal winged helix
domain. Both domains are independently able to bind
DNA in a sequence- and modification-specific manner.
This study defines the binding interface between the
DNA and wH domain with the help of a crystal struc-
ture. It was, so far, not possible to obtain a crystal struc-
ture with the DNA bound to the catalytic domain.
Therefore, this interaction was modeled based on the
structural similarity of R.DpnI to other PD-(D/E)XK
restriction endonucleases, which have been crystallized
with their DNA substrates. The resulting model is not
sufficiently accurate to reveal the atomic details of
sequence- or modification-specific recognition by the
catalytic domain. However, characterization of R.DpnI
variants with amino acid residues in the predicted
binding interface altered by site-directed mutagenesis
revealed that these residues are indeed important for
the enzyme activity (Supplementary Figures S9 and S10).
The finding that R.DpnI has two independent binding
sites for its target sequence can be interpreted in at least
two ways. First, the structural data do not absolutely
Figure 8. Pre-incubation of plasmid DNA with the R.DpnI wH
domain. M: molecular mass marker, ‘’: cleavage reaction without
pre-incubation with the wH domain, ‘+’: cleavage reaction after
pre-incubation with the wH domain (5-fold molar excess of wH
domain over Gm6ATC sites was used).
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exclude that catalytic and wH domain bind to the same
instance of one target site. In models that position both
domains on the same DNA (Supplementary Figure S9),
the resulting clashes between the domains are mild, and
the distances of 30 and 40 A˚ between the C-terminus of
the catalytic domain and the N-terminal end of the wH
domain (for the two alternative binding modes) could be
bridged by local refolding. However, the finding that
R.DpnI behaves kinetically like a type IIE enzyme
makes it more likely that the wH and catalytic domains
bind to two different instances of the target sequence. This
model avoids the need for local rearrangements in the
protein structure, and has several other attractive
features. First, the need for binding of two copies of the
target sequence should enhance fidelity. Thus, the model
helps to explain how relatively weak attractive van der
Waals interactions between the m6A methyl groups and
the protein can stringently license the enzymatic reaction
without violation of thermodynamic principles. Second,
for a monomeric restriction endonuclease, which can
introduce double-strand breaks in DNA only by sequen-
tial nicking, anchoring of the enzyme to another site in the
vicinity could be a good way to ensure that it completes
the cleavage of a nicked substrate. Recently, bioinformatic
analyses supported by mutagenesis showed that the
modification-dependent enzyme Mrr is also composed of
a wH and PD-(D/E)XK domains (33). It will be interest-
ing to determine whether Mrr and related modification-
dependent restriction enzymes will be similar to R.DpnI in
terms of the dependence on effector sites.
Modification dependence, a new theme in restriction
endonuclease structural research
Early structural studies of type II restriction endonucle-
ases were concentrated on the very widespread PD-(D/
E)XK enzymes and the mechanisms that explained the
exquisite specificity of these enzymes, mostly hydrogen
bonds and shape selection (34). Subsequent studies have
added to our understanding of DNA recognition by
indirect readout (35), semi-degenerate recognition
(36,37), and to unusual modes of DNA recognition by
nucleotide flipping (38,39), protein intercalation into
DNA (31,40) or disruption of the Watson–Crick pairing
(41). More recently, there has been much interest in the
crystallographic elucidation of structures of restriction
endonucleases that are phylogenetically unrelated to the
PD-(D/E)XK enzymes. This has led to the solution of
crystal structures of bba-Me (or HNH) (41,42),
GIY-YIG (43,44), half-pipe (45) and phospholipase-like
(46) restriction enzymes. The topic of modification-de-
pendent restriction endonucleases poses an interesting
puzzle: how can DNA cleavage depend on the presence
of a modification? As attractive van der Waals inter-
actions are much weaker than repulsive ones (47), this
question is much harder to answer than the reverse one
how DNA cleavage can be prevented. Surprisingly, this
question has been largely neglected, particularly by the
crystallographic community. Therefore, we anticipate





Supplementary Data are available at NAR Online:
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